Castle Biosciences vs Viemed Healthcare
Castle Biosciences reported revenue of $344 million in fiscal 2025, 1.3 times Viemed Healthcare's $270 million in fiscal 2025. Castle Biosciences' revenue grew 3.7% in its latest year, and Viemed Healthcare's grew 20.5%. Castle Biosciences had an operating margin of -12.4%, against 8.5% at Viemed Healthcare. Free cash flow was $28 million at Castle Biosciences and $12 million at Viemed Healthcare.
Side by side
| Castle Biosciences | Viemed Healthcare | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $344M | $270M |
| Revenue growth | 3.7% | 20.5% |
| Revenue growth a year, last 5 years | 40.6% | 15.5% |
| Gross margin | 79.4% | 57.5% |
| Operating margin | −12.4% | 8.5% |
| Net margin | −7.0% | 5.5% |
| Free cash flow | $28M | $12M |
| Free cash flow margin | 8.2% | 4.4% |
| Return on capital | −19.1% | 12.4% |
| Net debt to EBITDA | — | −0.0x |
| Dividends and buybacks | $0M | $13M |
| Change in diluted share count | −0.9% | 0.1% |
| Last close | $33.41 | $8.61 |
| P/E at the last close | — | 22.7× |
| Insider trades, last 12 months | sold $16.6 million | sold $1.6 million |
| Piotroski F-score | 4 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Castle BiosciencesViemed Healthcare
Operating margin
Percent of revenue
Castle BiosciencesViemed Healthcare
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Castle BiosciencesViemed Healthcare
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Castle Biosciences and Viemed Healthcare pages.